ATE466031T1 - Anti-hgf-r-antikörper und deren verwendung - Google Patents

Anti-hgf-r-antikörper und deren verwendung

Info

Publication number
ATE466031T1
ATE466031T1 AT04741691T AT04741691T ATE466031T1 AT E466031 T1 ATE466031 T1 AT E466031T1 AT 04741691 T AT04741691 T AT 04741691T AT 04741691 T AT04741691 T AT 04741691T AT E466031 T1 ATE466031 T1 AT E466031T1
Authority
AT
Austria
Prior art keywords
antibodies
hgf
relates
hfg
secretes
Prior art date
Application number
AT04741691T
Other languages
English (en)
Inventor
Maria Giovanna Prat
Original Assignee
Uni Degli Studi Del Piemonte O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi Del Piemonte O filed Critical Uni Degli Studi Del Piemonte O
Application granted granted Critical
Publication of ATE466031T1 publication Critical patent/ATE466031T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04741691T 2003-06-05 2004-06-01 Anti-hgf-r-antikörper und deren verwendung ATE466031T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001127A ITMI20031127A1 (it) 2003-06-05 2003-06-05 Anticorpi anti-hgf-r e loro uso
PCT/EP2004/050976 WO2004108766A2 (en) 2003-06-05 2004-06-01 Anti-hgf-r antibodies and their use

Publications (1)

Publication Number Publication Date
ATE466031T1 true ATE466031T1 (de) 2010-05-15

Family

ID=30131145

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04741691T ATE466031T1 (de) 2003-06-05 2004-06-01 Anti-hgf-r-antikörper und deren verwendung

Country Status (8)

Country Link
US (1) US7556804B2 (de)
EP (1) EP1641828B1 (de)
AT (1) ATE466031T1 (de)
CA (1) CA2524329A1 (de)
DE (1) DE602004026872D1 (de)
DK (1) DK1641828T3 (de)
IT (1) ITMI20031127A1 (de)
WO (1) WO2004108766A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8849001A1 (es) * 2008-11-21 2010-06-28 Lilly Co Eli Anticuerpos de c-met
CN102361884A (zh) 2009-04-07 2012-02-22 罗氏格黎卡特股份公司 双特异性抗-ErbB-2/抗-c-Met抗体
CN102378768A (zh) 2009-04-07 2012-03-14 罗氏格黎卡特股份公司 双特异性抗-ErbB-3/抗-c-Met抗体
KR101671378B1 (ko) * 2009-10-30 2016-11-01 삼성전자 주식회사 ｃ-Ｍｅｔ에 특이적으로 결합하는 항체 및 그의 용도
KR101748707B1 (ko) * 2009-11-27 2017-06-20 삼성전자주식회사 ｃ-Ｍｅｔ에 특이적으로 결합하는 항체 및 그를 이용한 암 진단용 키트
ITTO20091020A1 (it) * 2009-12-21 2011-06-22 Uni Degli Studi Del Piemonte Orientale Ame "cardiomyocytes anti-apoptotic molecules, products and compositions thereof"
EP3904391B1 (de) 2010-03-10 2024-07-10 Genmab A/S Monoklonale antikörper gegen c-met
EP3165538A1 (de) 2010-11-03 2017-05-10 Argen-X Nv Anti-c-met-antikörper
WO2013033008A2 (en) 2011-08-26 2013-03-07 Merrimack Pharmaceuticals, Inc. Tandem fc bispecific antibodies
EP2758430A4 (de) 2011-09-20 2015-06-03 Lilly Co Eli Anti-c-met-antikörper
EP2773660A2 (de) 2011-11-03 2014-09-10 Argen-X B.V. Chimäre mensch-kamel-antigene und ihre verwendung
US8900582B2 (en) 2011-12-22 2014-12-02 Samsung Electronics Co., Ltd. Deimmunized anti c-Met humanized antibodies and uses thereof
EP2727941A1 (de) 2012-11-05 2014-05-07 MAB Discovery GmbH Verfahren zur Herstellung multispezifischer Antikörper
WO2014067642A1 (en) 2012-11-05 2014-05-08 Mab Discovery Gmbh Method for the production of multispecific antibodies
SG11201506451UA (en) 2013-03-06 2015-09-29 Merrimack Pharmaceuticals Inc Anti-c-met tandem fc bispecific antibodies
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
EP3122900A1 (de) 2014-03-24 2017-02-01 F. Hoffmann-La Roche AG Krebsbehandlung mit c-met-antagonisten und korrelation desselben mit hgf-expression
MX378108B (es) 2014-09-16 2025-03-10 Servier Lab Anticuerpos anti-met y composiciones.
KR20170136536A (ko) 2015-03-16 2017-12-11 셀덱스 쎄라퓨틱스, 인크. 항-met 항체 및 그 사용 방법
US20200306283A1 (en) 2016-06-22 2020-10-01 William Warren HARLESS Cancer treatment and metastasis inhibition using an anti-cancer stem cell agent in combination with a neu1 sialidase inhibitor or a cytokine inhibitor after primary cancer treatment
GB201611123D0 (en) 2016-06-27 2016-08-10 Euremab Srl Anti met antibodiesand uses thereof
TWI782930B (zh) 2016-11-16 2022-11-11 美商再生元醫藥公司 抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
IT201800000535A1 (it) 2018-01-03 2019-07-03 Procedimenti per la cura del cancro.
KR102396194B1 (ko) * 2018-12-07 2022-05-10 서울대학교 산학협력단 항 c-Met 아고니스트 항체 및 이의 용도
KR102433184B1 (ko) * 2018-12-07 2022-08-17 서울대학교 산학협력단 항 c-Met 아고니스트 항체 및 이의 용도
CN114340684B (zh) 2019-09-16 2025-09-12 瑞泽恩制药公司 用于免疫pet成像的放射性标记的met结合蛋白

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3293823B2 (ja) * 1991-05-10 2002-06-17 フアルマシア・エ・アツプジヨン・エツセ・ピー・アー 肝細胞成長因子（ｈｇｆ）レセプターの部分切除形態
US5686292A (en) * 1995-06-02 1997-11-11 Genentech, Inc. Hepatocyte growth factor receptor antagonist antibodies and uses thereof
US6214344B1 (en) * 1995-06-02 2001-04-10 Genetech, Inc. Hepatocyte growth factor receptor antagonists and uses thereof
ATE465257T1 (de) 1996-07-03 2010-05-15 Genentech Inc Agonisten für den rezeptor des hepatozyten- wachstumsfaktors und deren anwendungen

Also Published As

Publication number Publication date
EP1641828B1 (de) 2010-04-28
CA2524329A1 (en) 2004-12-16
ITMI20031127A0 (it) 2003-06-05
EP1641828A2 (de) 2006-04-05
US7556804B2 (en) 2009-07-07
WO2004108766A3 (en) 2005-06-30
US20060140940A1 (en) 2006-06-29
ITMI20031127A1 (it) 2004-12-06
DE602004026872D1 (de) 2010-06-10
WO2004108766A2 (en) 2004-12-16
DK1641828T3 (da) 2010-08-02

Similar Documents

Publication Publication Date Title
DE602004026872D1 (de) Anti-hgf-r-antikörper und deren verwendung
NO20071436L (no) Humaniserte Anti-5T4 antistoffer og Anti-5T4 antistoff/calicheamicin konjugater
MY154009A (en) Anti-alpha v beta 6 antibodies
CY1110759T1 (el) Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
ATE495248T1 (de) Monoklonaler anti-cd20-antikörper
CY2012019I1 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
AR052284A1 (es) Variantes de un anticuerpo y usos de las mismas
UA97946C2 (ru) Моноклональное антитело, специфически связывающееся с внеклеточным доменом ilt7 человека
CY1117124T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ANTΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
DE602007013282D1 (de) Monoklonale antikörper gegen den humanen anti-müllerian-hormonrezeptor vom typ ii (amhr-ii)
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
DK1773885T3 (da) Humaniserede anti-c-met-antagonister
BR0011838B1 (pt) elemento de sela e estrutura de misturador estático.
CR9562A (es) Anticuerpos anti-cd40 humanizados y sus metodos de uso
DE602006013029D1 (de) Anti-egfr-antikörper
WO2006084092A3 (en) Antibodies to oncostatin m receptor
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
DK1519748T3 (da) Mikropartikler med CD28-specifikke monoklonale antistoffer
DE60042693D1 (de) Dosierung für die behandlung mit anti erbb2-antikörpern
EP4223778A4 (de) Anti-claudin18.2- und cd3-bispezifischer antikörper und verwendung davon
DK1411962T3 (da) Terapi for pancreacancer med monoklonalt stof
UA94211C2 (ru) Выделенное полностью человеческое моноклональное cd3 антитело
ATE451393T1 (de) Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln
EP4421092A4 (de) Bispezifischer anti-cd47-cldn18.2-antikörper und verwendung davon
UA98100C2 (ru) Гуманизированное моноклональное антитело, которое связывается с человеческим nogo и нейтрализует его

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1641828

Country of ref document: EP